India has dropped blood plasma from its treatment protocols. Now the big question is, does Remdesivir work against the virus? Watch: Over 100 patients were given fake Remdesivir injections in the Indian state of Madhya Pradesh and more than 90 per cent of them survived.

Does Remdesivir work against coronavirus?

The World Health Organization (WHO) has said that remdesivir has had little or no effect on coronavirus patients' length of hospital stay or chances of survival.

Remdesivir did not cut hospital stay or mortality in virus patients: WHO

The California-based drug makeing comoany Gilead Sciences has, after numerous months, got a green signal in Hong Kong for the usage of Remdesivir drug against coronavirus.

COVID 19: Gilead's Remdesivir gets a conditional green signal in Hong Kong

The United States has bought almost the entire worldwide stock of the anti-viral drug Remdesivir, which is being considered as a potential cure for coronavirus. As per an announcement made by the US Department of Health and Human Services (HSS) over 500,000 doses of the drug has been bought by the country from its sole manufacturer Gilead Sciences.

US purchases almost entire global stock of potential COVID-19 cure Remdesivir

With a rapid increase in the number of coronavirus cases in India, the country is gearing up to start domestic production of the anti-viral Remdesivir drug. The drug will be allowed only for "restricted emergency use" on COVID-19 patients.

COVID 19: India to start domestic production of Remdesivir

After India approved Remdesivir, South Korea on Wednesday issued emergency authorization for the anti-viral drug. Watch Video: The South Korean government said the drug had proved "clinically meaningful" in cutting patients' recovery time.

After India, South Korea approves Remdesivir for coronavirus patients

The Mongolian health ministry has requested for Remdesivir from Indian companies, India's envoy to Mongolia M P Singh has said. Remdesivir though still experimental holds promise in treatment for COVID.

Mongolia requests for Remdesivir used COVID treatment from Indian companies

Anti-viral drug remdesivir which was being hailed as the cure for the novel coronavirus, has failed its first clinical test. According to draft documents accidentally published by the World Health Organization, a Chinese trial showed that the drug did not improve patients' condition or reduce the pathogen's presence in the bloodstream.

Anti-viral drug being hailed as coronavirus cure, fails first clinical trial